Ballew Advisors’s CVS Health CVS Stock Holding History

Ballew Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-334	Closed	-$23K	–	160
2018 Q3	$23K	Hold	334	–	–	0.02%	225
2018 Q2	$22K	Hold	334	–	–	0.02%	228
2018 Q1	$21K	Buy	+334	New	+$24K	0.02%	237

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ballew Advisors's CVS Position: Q4 2018 in Review

Ballew Advisors sold out of CVS Health (CVS) in Q4 2018, closing a stake of 334 shares — an estimated $23K sold.

Ballew Advisors first reported a position in CVS in Q1 2018 and held it in 3 quarters. The position peaked at $23K in Q3 2018. 1,779 funds tracked by Wall St. Rank hold CVS as of Q4 2018.

Ballew Advisors reported no remaining CVS Health position as of Q4 2018 after selling out during the quarter.
Ballew Advisors sold 334 CVS Health shares in Q4 2018, an estimated $23K.
Ballew Advisors first reported a position in CVS Health in Q1 2018 and held it in 3 quarters.
Ballew Advisors's CVS Health position peaked at $23K in Q3 2018.
1,779 funds tracked by Wall St. Rank held CVS Health as of Q4 2018.

Based on Ballew Advisors's 13F filing for Q4 2018, filed 12 Feb 2019.